MVC SNMMI

Official Twitter account for the Missouri Valley Chapter of the Society of Nuclear Medicine and Molecular Imaging

[SNMMI @SNM_MI]

Congratulations SNMMI-TS on the 1st Technologist Theranostics Tumor Board (T3B). Presenters examined key components when treating patients with 177Lu-Vipivotide Tetraxetan (Pluvicto®), recognized challenges when delivering 177Lu-Vipivotide Tetraxetan (Pluvicto®) therapy, & more.

[JNM @JournalofNucMed]

In memoriam: Aruna Bodapati Gambhir, 1962-2023. https://t.co/YoGUzxMNYx

[SNMMI @SNM_MI]

PET imaging with ⁶⁸Ga-FAPI can more effectively detect and stage pancreatic cancer compared with ¹⁸F-FDG imaging or contrast-enhanced CT, according to research from @JournalofNucMed. Read more: https://t.co/UqL5JZcgIg

#NuclearMedicine #PancreaticCancer #MolecularImaging

[JNM @JournalofNucMed]

New PET tracer visualizes and quantifies MAGL in preclinical studies and has the potential to enable precision pharmacology during drug development for neurological disorders. https://t.co/UQyv2hACTN

#PETimaging #NuclearMedicine @he_yingfan27720 @LinjingM

[JNM @JournalofNucMed]

Tumor location relative to the spleen is a prognostic factor in #lymphoma patients: A demonstration from the REMARC trial. https://t.co/GsMmfHN6uY

#MolecularImaging #ArtificialIntelligence @kibrom2b @IreneBuvat

[JNM @JournalofNucMed]

A summary of the SNMMI procedure standard/EANM practice guideline for estrogen receptor imaging of patients with #BreastCancer using ¹⁸F-FES PET: https://t.co/1rQszqwgzB

#NuclearMedicine #MedicalImaging @SNM_MI @EANM_NucMed

[JNM @JournalofNucMed]

Uptake of ⁶⁸Ga-NODAGA-RGD is a potentially relevant biomarker in acute #MyocardialInfarction and might identify patients who could benefit from therapeutic interventions. https://t.co/lc2y6hQ2i8

#MolecularImaging #MedicalImaging @wnammas

[JNM @JournalofNucMed]

Unraveling the impact of ¹⁷⁷Lu-PSMA radioligand therapy on renal impairment: Distinguishing causation from correlation. https://t.co/fUUempwvkG

#RPTherapy #NuclearMedicine #ProstateCancer @DrMHofman

[JNM @JournalofNucMed]

The future of radionuclide myocardial perfusion imaging: Transitioning from SPECT to PET. https://t.co/czfYWwHsJM

JNM: Home of #NuclearCardiology

#NuclearMedicine #CoronaryArteryDisease @mdicarli

[JNM @JournalofNucMed]

Quantitative perfusion imaging with total-body PET: https://t.co/UvWN8gbBRQ

JNM: Home of #NuclearCardiology

#PETscan #MedicalImaging @JuhaniKnuuti

[JNM @JournalofNucMed]

A comprehensive survey of state-of-the-art #AI methods for PET and SPECT image enhancement: https://t.co/iwfd5jW9nP

#MedicalImaging #MolecularImaging @vibha_balaji @JoyitaDutta

[JNM @JournalofNucMed]

The hierarchy of SUVs: a simple common-sense concept! https://t.co/7n2WShI0DM

#NuclearMedicine #Theranostics #PETscan @DrMHofman

[JNM @JournalofNucMed]

Infection imaging: Focus on new tracers? https://t.co/FWQ3e2fDBj

#NuclearMedicine #InfectiousDisease #MedicalImaging

[JNM @JournalofNucMed]

A new frontier in #MolecularImaging: Imaging agents for PET of inflammatory bowel disease. https://t.co/YGl3bzEwJe

#NuclearMedicine #IBD @Rezazadeh_F

[JNM @JournalofNucMed]

Pre-targeted TAT with ²¹²Pb in pancreatic ductal adenocarcinoma is safe and feasible and a promising strategy for improving patient care. https://t.co/tX5ty8jPiO

#NuclearMedicine #RPTherapy #PancreaticCancer @LewisLabMSKCC

[JNM @JournalofNucMed]

PET/MRI can reveal thymus activation in addition to local lymph node reactions in children after #COVID19 vaccination. https://t.co/yzgqOhMkGV

#NuclearMedicine #MedicalImaging @gluthria

[JNM @JournalofNucMed]

Important ethical AI considerations: https://t.co/lbNsV93Jfu

#AI #MedicalImaging #NuclearMedicine @babaksaboury @JCCHerington

[SNMMI @SNM_MI]

This year, the tracer principle - a key concept within nuclear medicine, molecular imaging, and radiotheranostics - turns 100 years old. https://t.co/Bga9GtGKy6

#NuclearMedicine #Theranostics #MolecularImaging @DrAGafita @radnucmp @SHoberueck

[UroToday.com @urotoday]

@SNM_MI consensus statement on patient selection and appropriate use of 177Lu-PSMA-617 radionuclide therapy. @thomashopemd @UCSF and @PhillipKooMD @BannerHealth discuss the @JournalofNucMed published statement in this conversation on UroToday > https://t.co/H1RsT59Zb2

[JNM @JournalofNucMed]

Expanding indications? Somatostatin receptor expression in lung neuroendocrine tumors: An analysis of DOTATATE PET scans. https://t.co/bEOM8qpqDH

#NuclearMedicine #PETscan #NETCancer @altoubaht @moffittnews